Digest Network Come funziona
Network
/
Società
Ta
Non verificato

Tangram Therapeutics PLC

Di cosa scriviamo

Annunci EconomiciBiotecnologiaMedicina Salute Benessere

4 comunicati stampa

Guarda tutti i comunicati
26/11/2025
Biotecnologia
Tangram Therapeutics soumet une demande d’essai clinique pour une étude de phase 1/2 du TGM-312, un nouveau candidat ARNi expérimental pour le traitement de la MASH
Fonte
Tangram Therapeutics PLC
Emittente
GLOBENEWSWIRE
1.00
0
26/11/2025
Biotecnologia
Tangram Therapeutics Submits Clinical Trial Application for Phase 1/2 Study of TGM-312, a Novel Investigational RNAi MASH Candidate
Fonte
Tangram Therapeutics PLC
Emittente
GLOBENEWSWIRE
1.00
0
01/10/2025
Biotecnologia
Medicina Salute Benessere
Annunci Economici
e-therapeutics relance son activité sous le nom de Tangram Therapeutics et présente LLibra OS
Fonte
Tangram Therapeutics PLC
Emittente
GLOBENEWSWIRE
1.00
0
01/10/2025
Biotecnologia
Medicina Salute Benessere
Annunci Economici
e-therapeutics Relaunches as Tangram Therapeutics and Unveils LLibra OS
Fonte
Tangram Therapeutics PLC
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0